Ara
Toplam kayıt 3, listelenen: 1-3
Advantage of the Subcutaneous Immunoglobulin Replacement Therapy in Primary Immunodeficient Patients With or Without Secondary Protein Loss
(Turkish J Pediatrics, 2018)
In recent years subcutaneous immunoglobulin is widely used for primary immunodeficient patients. Subcutaneous administration provides a more stable and higher serum immunoglobulin levels due to continuous and steady ...